• Subscribe
    • Sign up for updates about the journal.
  • Sign in
  • Register
Exploration of Targeted Anti-tumor Therapy
  • About
    • About the Journal
    • Editorial Board
    • Editorial Policies
    • Newsletter
    • Contact Us
  • Articles
    • Current Volume
    • Archives
  • Special Issue
    • All Special Issues
    • Guest Editor Guidelines
  • For Authors
    • Author Instructions
    • Editorial Process
    • Article Processing Charge
    • Submit a Manuscript
  • For Reviewers
    • Peer Review Guidelines
    • Reviewer Acknowledgment
    • To Be a Reviewer
  • Focus
  • Home
  • Times Cited
  • Citing Article List
  • Abstract
  • Keywords
  • Introduction
  • Chemistry of BD
  • Antineoplastic effects of BD in human malignancies
  • Anti-metastatic effects of BD
  • Potential anti-inflammatory effects of BD
  • Pharmacokinetics, toxicity and metabolism
  • Clinical application of BD
  • Conclusion and future directions
  • Abbreviations
  • Declarations
  • References

  • Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer”.
    No. Publication Date Citing Article
    1 2024 Yifan Hou, Zhenhua Zhao, Pan Li, Yujia Cao, Yi Zhang, Changsheng Guo, Xiaobo Nie, Junqing Hou. Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024; 1879: 189186189186.  https://doi.org/10.1016/j.bbcan.2024.189186
    2 2024 Vignesh Sivaganesh, Tram M. Ta, Bela Peethambaran. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway, International Journal of Molecular Sciences. 2024; 25: 7003.  https://doi.org/10.3390/ijms25137003
    3 2024 Lin Li, Weixue Huang, Xiaomei Ren, Zhen Wang, Ke Ding, Linxiang Zhao, Jinwei Zhang. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies, Science China Life Sciences. 2024; 67: 2603.  https://doi.org/10.1007/s11427-024-2685-9
    • Submit a Manuscript
    • Aims and Scope
    • Editorial Board
    • Author Instructions
    • Exploration of Targeted Anti-tumor Therapy
    • eISSN 2692-3114
    • etatjournal@explorationpub.com
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Editorial Policies
    • Editorial Process
    • Follow the Journal
    • JOURNALS
    • Exploration of Medicine
    • Exploration of Targeted Anti-tumor Therapy
    • Exploration of Immunology
    • Exploration of Neuroprotective Therapy
    • Exploration of Neuroscience
    • Exploration of Digestive Diseases
    • Exploration of Musculoskeletal Diseases
    • Exploration of Drug Science
    • Exploration of Asthma & Allergy
    • Exploration of Foods and Foodomics
    • Exploration of Digital Health Technologies
    • Exploration of Cardiology
    • Exploration of BioMat-X
    • Exploration of Endocrine and Metabolic Diseases
    • ABOUT
    • Company Information
    • Open Access
    • Editorial Policies
    • Peer Review Policy
    • Contact Us
    • FOLLOW
    • Terms of Service Privacy Cookies
Copyright © 2024 Open Exploration Publishing Inc.